# Evaluation of Oral Minocycline in the Treatment of Geographic Atrophy Associated With Age-Related Macular Degeneration

> **NCT02564978** · PHASE2 · COMPLETED · sponsor: **National Eye Institute (NEI)** · enrollment: 37 (actual)

## Conditions studied

- Age-Related Macular Degeneration

## Interventions

- **DRUG:** Minocycline

## Key facts

- **NCT ID:** NCT02564978
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-14
- **Primary completion:** 2022-09-28
- **Final completion:** 2023-03-08
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2025-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02564978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02564978, "Evaluation of Oral Minocycline in the Treatment of Geographic Atrophy Associated With Age-Related Macular Degeneration". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02564978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*